Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Life Science

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0024-3205(91)90249-BPMID 1875792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of biological actions of big endothelin-1 by phosphoramidon.

  1990cited by this paper
• Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage

  1990cited by this paper
• Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.

  1990cited by this paper
• Conversion of big endothelin‐1 to endothelin‐1 by two types of metalloproteinases derived from porcine aortic endothelial cells

  1990cited by this paper
• Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage.

  1990cited by this paper
• Conversion of big endothelin-1 by membrane-bound metalloendopeptidase in cultured bovine endothelial cells.

  1990cited by this paper
• Effect of endothelin on the canine basilar artery.

  1990cited by this paper
• The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase).

  1990cited by this paper
• Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance.

  1990cited by this paper
• Endothelin: a potential modulator of cerebral vasospasm.

  1990cited by this paper
• Effect of Endothelin on the Canine Basilar Artery

  1990cited by this paper
• Enhanced vasoconstrictor effect of endothelin in cerebral arteries from rats with subarachnoid haemorrhage.

  1990cited by this paper
• Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme.

  1990cited by this paper
• Raised plasma endothelin in aneurysmal subarachnoid haemorrhage.

  1989cited by this paper
• The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage.

  1989cited by this paper
• Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1

  1989cited by this paper
• Conversion of Big Endothelin‐1 to 21‐Residue Endothelin‐1 Is Essential for Expression of Full Vasoconstrictor Activity: Structure‐Activity Relationships of Big Endothelin‐1

  1989cited by this paper
• Endothelin acts in feline and canine cerebral arteries from the adventitial side.

  1989cited by this paper
• Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo

  1989cited by this paper
• Endothelin and the production of cerebral vasospasm in dogs.

  1989cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Experimental vasospasm: experiences with a canine model and failure of naloxone therapy.

  1984cited by this paper
• Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.

  1983cited by this paper
• Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisolone.

  1983cited by this paper
• Attempted prevention or treatment of intracranial arterial spasm: a survey.

  1980cited by this paper
• Cerebral vasospasm with ruptured saccular aneurysm--the clinical manifestations.

  1977cited by this paper

• Current and future strategies for targeting the endothelin pathway in cardiovascular disease

  2023cites this paper
• Bibliometric Analysis of the Top 100 Most Cited Articles on Cerebral Vasospasm.

  2020cites this paper
• Endothelin and the heart in health and diseases

  2019cites this paper
• Built to bind: biosynthetic strategies for the formation of small-molecule protease inhibitors.

  2019cites this paper
• Endothelin-1 levels in serum and cerebrospinal fluid after vasospasm following spontaneous subarachnoid hemorrhage

  2019cites this paper
• Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Experimental-Clinical Disconnect and the Unmet Need

  2019cites this paper
• ndothelin-1 levels in serum and cerebrospinal fluid after vasospasm following spontaneous subarachnoid hemorrhage

  2019cites this paper
• Signalling and Regulation of the Glucagon-like Peptide-1 receptor

  2014cites this paper
• Inflammation, Vasospasm, and Brain Injury after Subarachnoid Hemorrhage

  2014cites this paper
• Brain endothelial barrier passage by monocytes is controlled by the endothelin system

  2012cites this paper
• The Clinical Potential of Endothelin Receptor Antagonists in Cardiovascular Medicine

  2012cites this paper
• Pharmacologic Reduction of Angiographic Vasospasm in Experimental Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis

  2012cites this paper
• From bench-to-bedside in catastrophic cerebrovascular disease: development of drugs targeting the endothelin axis in subarachnoid hemorrhage-related vasospasm

  2012cites this paper
• Textbook of interventional neurology

  2011cites this paper
• Inflammation and cerebral vasospasm after subarachnoid hemorrhage.

  2010cites this paper
• Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage.

  2010cites this paper
• Role of endogenous endothelin-1 in post-ischemic cardiac dysfunction and norepinephrine overflow in rat hearts.

  2008cites this paper
• Review ar tide Do we need endothelin antagonists?

  2007cites this paper
• Design and synthesis of diversely substituted azacyclic inhibitors of endothelin converting enzyme.

  2006cites this paper
• Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm

  2006cites this paper
• Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.

  2005cites this paper
• Endothelin-1 levels in plasma and cerebrospinal fluid of patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

  2005cites this paper
• The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm

  2004cites this paper
• Endothelins and the role of endothelin antagonists in the management of posttraumatic vasospasm.

  2004cites this paper
• Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment.

  2004cites this paper
• An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage.

  2004cites this paper
• Endothelin receptor antagonists and cerebral vasospasm

  2004cites this paper
• Endothelin receptor antagonists and cerebral vasospasm

  2004cites this paper
• [D-Val22]big ET-1[16–38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm

  2003influential citation
• The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels

  2003cites this paper
• The Effect of EGb‐761 on Morphologic Vasospasm in Canine Basilar Artery after Subarachnoid Hemorrhage

  2003cites this paper
• Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.

  2002cites this paper
• Attenuation of SAH-induced cerebral vasospasm by a selective ECE inhibitor

  2002cites this paper
• Endothelin Receptor Antagonists and Cerebral Vasospasm: An Update

  2002cites this paper
• Attenuation of hemolysate-induced cerebrovascular endothelial cell injury and of production of endothelin-1 and big endothelin-1 by an endothelin-converting enzyme inhibitor.

  2002cites this paper
• Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction of rabbit basilar artery.

  2002cites this paper
• Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications.

  2002cites this paper
• Effect of Endothelin-Converting Enzyme Inhibitors on big Endothelin-1 Induced Contraction in Isolated rat Basilar Artery

  2002cites this paper
• Endothelin-converting Enzyme Activity in Human Cerebral Circulation

  2002cites this paper
• Inhibition of Endothelin-converting Enzyme Activity in the Rabbit Basilar Artery

  2001influential citation
• The Involvement of Endothelins in Cerebral Vasospasm and Stroke

  2001cites this paper
• Endothelin and Its Inhibitors

  2001cites this paper
• Temporal Relationship Between Endothelin-1 Concentrations and Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage

  2001cites this paper
• Continuous Intravenous Infusion of CGS 26303, an Endothelin-converting Enzyme Inhibitor, Prevents and Reverses Cerebral Vasospasm after Experimental Subarachnoid Hemorrhage

  2001cites this paper
• Pathology and Pathogenesis

  2001cites this paper
• Gene therapy for vasospasm.

  2001cites this paper
• Mechanisms Of Endothelin‐1‐Induced Potentiation Of Noradrenaline Response In Rat Mesenteric Artery

  2001cites this paper
• Endothelin-Converting Enzyme Inhibitors and their Effects

  2001cites this paper
• Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats.

  2001cites this paper
• Chapter 6 – Pharmacology

  2001cites this paper
• Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery.

  2000cites this paper
• Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats.

  2000cites this paper
• Doxorubicin, an RNA synthesis inhibitor, prevents vasoconstriction and inhibits aberrant expression of endothelin-1 in the cerebral vasospasm model of the rat.

  2000cites this paper
• Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme.

  2000cites this paper
• Effect of endothelin receptor antagonists on non-muscle matrix compaction in a cell culture vasospasm model

  2000cites this paper
• Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage.

  2000cites this paper
• [Subarachnoid hemorrhage, cerebral ischemia and endothelin-1].

  2000cites this paper
• Effects of endothelin-converting enzyme inhibitors on hemolysate-induced morphological changes and production of endothelin-1 in bovine cerebrovascular endothelial cells.

  2000cites this paper
• Hemorragia subaracnoidea, isquemia cerebral y endotelina-1

  2000cites this paper
• Endothelial modulation of vascular tone.

  2000cites this paper
• Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC.

  1999cites this paper
• Pathophysiology of endothelin in the cardiovascular system.

  1999cites this paper
• Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC.

  1999cites this paper
• Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.

  1999cites this paper
• Pathophysiological Role of Endothelin and Potential Therapeutic Targets for Receptor Antagonists

  1998cites this paper
• Endothelins – vasoactive peptides and growth factors

  1998cites this paper
• Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.

  1998cites this paper
• SUBARACHNOID HAEMORRHAGE: WHAT HAPPENS TO THE CEREBRAL ARTERIES?

  1998cites this paper
• Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.

  1998cites this paper
• Endothelin and subarachnoid hemorrhage: an overview.

  1998cites this paper
• Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707.

  1998cites this paper
• Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm.

  1998cites this paper
• Endothelin-1 enhances pressor responses to norepinephrine: involvement of endothelin-B receptor.

  1998cites this paper
• Effects of endothelin-1 on norepinephrine-induced vasoconstriction in deoxycorticosterone acetate-salt hypertensive rats.

  1998cites this paper
• Effects of dual endothelin-converting enzyme/neutral endopeptidase inhibitors, CGS 26303 and CGS 26393, on lipopolysaccharide or interleukin-1 beta-stimulated release of endothelin from guinea pig tracheal epithelial cells.

  1998cites this paper
• Influence endothelin ETA receptor antagonist--BQ-123--on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage.

  1998cites this paper
• Regulation of the cerebral circulation: role of endothelium and potassium channels.

  1998cites this paper
• Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage.

  1997cites this paper
• Platelets enhance contractility in perfused rat mesenteric arteries: involvement of endothelin-1.

  1997cites this paper
• Amlodipine and benazeprilat differently affect the responses to endothelin-1 and bradykinin in porcine ciliary arteries: effects of a low and high dose combination.

  1997cites this paper
• Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries.

  1997cites this paper
• Thromboxane A2-receptor blockade improves cerebral protection for deep hypothermic circulatory arrest.

  1997cites this paper
• Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage.

  1997cites this paper
• Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse.

  1997cites this paper
• Attenuation of cerebral vasospasm by systemic administration of an endothelin-A receptor antagonist, TBC 11251, in a rabbit model of subarachnoid hemorrhage.

  1997cites this paper
• Role of lysophosphatidic acid in endothelin-1- and hematoma-induced alteration of cerebral microcirculation.

  1997cites this paper
• Effects of deferoxamine and sympathectomy on endothelin-1-induced contraction and acetylcholine-induced relaxation following subarachnoid hemorrhage in carotid artery.

  1997cites this paper
• Source and cause of endothelin-1 release to cerebrospinal fluid after subarachnoid hemorrhage

  1997cites this paper
• Role of endothelin-1 in cerebral hematoma-induced modification of cerebral vascular reactivity in piglets.

  1996cites this paper
• Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.

  1996cites this paper
• The endothelin system and its potential as a therapeutic target in cardiovascular disease.

  1996cites this paper
• Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys.

  1996cites this paper
• Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.

  1996cites this paper
• Molecular pharmacology and pathophysiological significance of endothelin.

  1996cites this paper
• Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries

  1996cites this paper
• POTENTIAL ROLES FOR ENDOTHELINS IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROME WITH A PARTICULAR RELATIONSHIP TO CYTOKINES

  1996cites this paper
• Endothelin-1 secretion from cultured vascular endothelial cells of DOCA-salt hypertensive rats.

  1996cites this paper
• Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists.

  1996cites this paper
• [Prevention of cerebral vasospasms after experimental subarachnoid hemorrhage by the endothelin receptor antagonist RO 47-0203].

  1996cites this paper
• Endothelins and the cerebral circulation.

  1995cites this paper